A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2006
11/14/2006	US7135489 Cyclooxygenase inhibitors; antiinflammatory agents
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135476 Corticotropin releasing factor antagonists; anxiolytic agents; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,8'-(7H)quinazoline]; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,7'-(5H)cyclopentapyrimidine]
11/14/2006	US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135454 Use of SLURP-1 compositions for treating schizophrenia
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/14/2006	US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
11/14/2006	US7135181 Method for down-regulation of amyloid
11/14/2006	CA2417887C Particulate composition of eletriptan
11/14/2006	CA2379572C Polymorphic salt
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2296427C 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives
11/14/2006	CA2294783C Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
11/14/2006	CA2263846C Novel pyranoside derivatives
11/14/2006	CA2156432C New derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/14/2006	CA2100812C Substituted aminothienopyridines, a process for their preparation and their use as medicaments
11/12/2006	CA2546392A1 Phenylpyridinylpiperazine derivatives, a process for their preparation and pharmaceutical compositions containing them
11/12/2006	CA2546387A1 Phenyl-pyridinyl-piperazine derivatives, process for the preparation thereof and pharmaceutical compositions containing said derivatives
11/09/2006	WO2006118719A2 Method of improving learning and memory in mammals
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006118307A1 Therapeutic agent for pain
11/09/2006	WO2006118299A1 Gpcr inhibitor
11/09/2006	WO2006118289A1 Method for identification of compound having antidepressant effect
11/09/2006	WO2006118265A1 Composition containing antidementia agent
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118196A1 Dpp4 inhibitor and pharmaceutical application thereof
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006118074A1 Composition for inducing sleep containing vegetable essential oil component as the active component, transdermal absorption type sleep inducing agent containing the composition and method of producing the same
11/09/2006	WO2006117614A1 Process for the preparation of pramipexole and new anhydrous forms of its dihydrochloride
11/09/2006	WO2006117611A1 Histamine h3-recept0r ligands and their therapeutic application
11/09/2006	WO2006117573A1 Combination therapy
11/09/2006	WO2006117548A1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity
11/09/2006	WO2006117461A2 Alkyl-, alkenyl- et alkynyl carbamate derivatives, the preparation and therapeutic use thereof
11/09/2006	WO2006117400A2 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors
11/09/2006	WO2006117305A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	WO2006117221A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders
11/09/2006	WO2006117170A1 Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons
11/09/2006	WO2006116862A1 Method for inhibiting er stress-induced apoptosis
11/09/2006	WO2006116848A1 Substituted butyrophenone derivatives
11/09/2006	WO2006116808A1 Treating peripheral neuropathies
11/09/2006	WO2006094704A3 Natural ligand of g protein coupled receptor rcc356 and uses thereof
11/09/2006	WO2006072828A3 Heteroaromatic quinoline compounds and their use as pde10 inhibitors
11/09/2006	WO2006019673A3 Jiadifenin analogs and uses thereof
11/09/2006	WO1998035042A8 Activity dependent neurotrophic factor iii (adnf iii)
11/09/2006	US20060252934 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252835 Modafinil polymorphic forms
11/09/2006	US20060252833 Improve efficiency when administered with conventional drugs; side effect reduction; Parkinson's disease therapy; administering a fatty acid
11/09/2006	US20060252824 Substance with sedative effect
11/09/2006	US20060252822 Mitochrondrial permeability transition pore affinity labels and modulators
11/09/2006	US20060252820 Composition for oral administration containing alkylene dioxybenzene derivative
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006	US20060252790 e.g. 5-{5-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine; antiinflammatory agent, antiallergen; cognitive impairment; asthma, arthritis
11/09/2006	US20060252784 Imidazo-substituted 1,8-naphthyridinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252783 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252780 Fused pyrimidine derivatives
11/09/2006	US20060252768 2,3,6-Trisubstituted-4-pyrimidone derivatives
11/09/2006	US20060252765 Corneal perception recovery drug containing amide compound
11/09/2006	US20060252753 N-methyl-N-[2-( 1-pyrrolidinyl)cyclohexyl]-3,4-dichlorocinnamide monohydrochloride;
11/09/2006	US20060252747 Substitituted 1-piperidin-3-yl-piperidin 4-yl-piperazine derivatives and their use as neurokinin auantagonists
11/09/2006	US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006	US20060252681 Pain relief agents
11/09/2006	US20060252677 Postsynaptic proteins
11/09/2006	US20060252676 Analgesic antitumor peptide from scorpion and method of producing it
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060251578 Therapeutic and diagnostic compounds, compositions, and methods
11/09/2006	DE102005020401A1 Use of local anesthetic (from anilide groups) in the preparation of medicaments to treat diseases such as nervous system (e.g. dementia, Parkinson's disease and depression)
11/09/2006	DE102005014142B4 Pelletförmige Retardzubereitung gegen Schwindel Delayed-release pellet shaped against scams
11/09/2006	CA2607506A1 Novel lactam compound
11/09/2006	CA2607227A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	CA2606757A1 Substituted butyrophenone derivatives
11/09/2006	CA2606515A1 Method of improving learning and memory in mammals
11/09/2006	CA2606489A1 Method for identification of compound having antidepressant effect
11/09/2006	CA2606269A1 Histamine h3-recept0r ligands and their therapeutic application
11/09/2006	CA2606262A1 Novel histamine h3-receptor ligands and their therapeutic applications
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2606151A1 Composition for sleep inducer comprising essential oil as active ingredient, percutaneous sleep inducer comprising thereof, and method for producing thereof
11/09/2006	CA2605759A1 Antibodies directed against amyloid-beta peptide and methods using same
11/09/2006	CA2605473A1 Process for preparing quetiapine and quetiapine fumarate
11/09/2006	CA2604617A1 Composition containing anti-dementia drug
11/09/2006	CA2591586A1 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1719757A1 Bicyclo derivative

1 ... 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 ... 1833